&Partners’s Sanofi SNY Stock Holding History

&Partners’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.36M	Sell	149,234 -2,641	-2%	-$118K	0.03%	511
2026 Q1	$7.23M	Buy	151,875 +14,184	+10%	+$661K	0.04%	426
2025 Q4	$6.66M	Buy	137,691 +7,322	+6%	+$363K	0.03%	405
2025 Q3	$6.11M	Buy	130,369 +12,273	+10%	+$592K	0.04%	373
2025 Q2	$5.71M	Buy	118,096 +18,469	+19%	+$944K	0.04%	339
2025 Q1	$5.59M	Buy	99,627 +7,988	+9%	+$432K	0.06%	276
2024 Q4	$4.43M	Buy	91,639 +32,215	+54%	+$1.64M	0.05%	299
2024 Q3	$3.43M	Buy	59,424 +34,683	+140%	+$1.87M	0.07%	261
2024 Q2	$1.2M	Buy	24,741 +14,979	+153%	+$723K	0.05%	301
2024 Q1	$474K	Buy	+9,762	New	+$477K	0.07%	276

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

&Partners's SNY Position: Q2 2026 in Review

&Partners reduced its Sanofi (SNY) stake by 1.7% in Q2 2026, selling an estimated $118K and leaving 149,234 shares worth $6.36M. The position accounts for 0.03% of the portfolio, ranked #511.

&Partners first reported a position in SNY in Q1 2024 and has held it in 10 quarters since. The position peaked at $7.23M in Q1 2026. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

&Partners held 149,234 shares of Sanofi worth $6.36M as of Q2 2026.
&Partners sold 2,641 Sanofi shares in Q2 2026, an estimated $118K.
Sanofi made up 0.03% of &Partners's portfolio in Q2 2026, its #511 holding.
&Partners first reported a position in Sanofi in Q1 2024 and has held it in 10 quarters since.
&Partners's Sanofi position peaked at $7.23M in Q1 2026.
716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.